Viewing Study NCT00532194

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2026-03-02 @ 4:24 PM
Study NCT ID: NCT00532194
Status: UNKNOWN
Last Update Posted: 2015-09-23
First Post: 2007-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer
Sponsor: Medical Research Council
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ovarian cancer View
None fallopian tube cancer View
None primary serous peritoneal cancer View
None gynaecological carcinoma View
None randomised controlled trial View
None Cediranib View
None AZD2171 View
None efficacy View